TRACON Pharmaceuticals (TCON)
(Delayed Data from OTC)
$0.66 USD
+0.03 (4.78%)
Updated Jul 25, 2024 02:23 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
TCON 0.66 +0.03(4.78%)
Will TCON be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for TCON based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TCON
Tracon (TCON) Moves to Buy: Rationale Behind the Upgrade
TCON: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for TCON
TRACON Pharmaceuticals Announces Executive Officer Resignation
12 Health Care Stocks Moving In Monday's Pre-Market Session
Biotech Alert: Searches spiking for these stocks today
Why Broadcom Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
Why Streamline Health Solutions Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session